Nexus ScreenerKLRS stock: Kalaris Therapeutics, Inc.
Kalaris Therapeutics, Inc. (KLRS) has been one of the market’s top momentum runners on 1 day, most recently November 6, 2026. Here is every run the scanner recorded, the news behind it, and what to check before trading it.
KLRS’s runs
Against the price when the scanner flagged it: the regular session’s highest price after the flag, and the 4:00 PM close. Next-day results and the full dilution risk score are in Nexus Pro.
SEC filings to know about
No offering filings or reverse splits from KLRS in the last 30 days.
Offerings and reverse splits often come before a stock falls. The dilution guide explains what to look for; the app scores each stock’s dilution risk from its cash runway and share count.
See KLRS live: chart with VWAP and key levels, float, relative volume, news, filings and alerts when it runs again.
Open KLRS in the appQuestions
How often has KLRS been a top runner?
The Nexus Screener scanner flagged KLRS as a Supernova (up 10% or more on heavy volume) on 1 day since November 6, 2026.
Is KLRS a low-float stock?
KLRS has a free float of about 5.9M shares, under the 20M that traders usually call low float, so it can move sharply on heavy volume.